Company intelligence / Profile preview
Quratis
Cheongju-si, Chungcheongbuk-do, South Koreaquratis.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Quratis’ lead tuberculosis vaccine candidate has advanced through global Phase 1 and Phase 2a trials in adolescents/adults, with a global phase 2b/3 IND approved. The company’s pipeline includes additional preclinical assets targeting infectious diseases, cancer, autoimmune disorders, and schistosomiasis. Its Osong Bio Plant holds GMP certification and has produced clinical samples for mRNA vaccines.
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- VaccineRecombinant proteinInactivated vaccineProphylactic vaccineCell therapyasPNAmRNA-based drugs
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
Infectious Disease Research Institute / IDRI – exclusive license agreement for TB vaccine developmentBio Farma PT – term sheet agreement to develop/commercialize TB vaccines in IndonesiaHDT Bio – MOU for COVID mRNA vaccine productionShandong Lukang Hao Li You – joint development contract for tuberculosis vaccineRIGHT Foundation/Bill & Melinda Gates Foundation support on TB/schisto projects
Beyond the preview
Go deeper on Quratis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Quratis.